Gudrun Bachmann

Gudrun Bachmann serves as Chief Technology Officer at Oculis. Oculis operates in the research sector with approximately 58.0 employees. The company is headquartered in Geneva, Geneva. Oculis generates annual revenue of 1044000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 305 executive contacts are available in Geneva.
• • Our database includes 201,469 c suite-level executives.

Outlook Adobe Marketing Cloud Google Analytics reCAPTCHA Google Maps Gravity Forms WordPress.org Google Maps (Non Paid Users) Google Tag Manager Google Font API Shutterstock Mobile Friendly Apache Remote Data Analytics AI

pharmaceutical ophthalmology drug delivery biotech biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical eye care diabetic macular edema dme ocs-01 high concentration eye drop non-invasive treatment anti-vegf therapies dry eye disease ded ocs-02 anti-tnf eye drop ocular inflammation uveitis acute optic neuritis aon ocs-05 neuroprotective therapy optireach technology clinical trials pipeline patient-centric transformative innovations investigational drugs visual impairment cataract surgery post ocular surgery inflammation pain management topical administration drug passage ocular complications ocular disease patient population advanced therapies therapeutic innovation scientific approaches investors medical needs regulatory approval sight saving health improvement medical research ophthalmic products therapy development global healthcare medical innovation evidence-based medicine medical health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Gudrun Bachmann in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Oculis.

Gudrun Bachmann's Position in the MessageCEO Database

• •Gudrun Bachmann is 1 of 1 verified executive contact we track at Oculis.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •299 verified executive contacts in Geneva are in the database.
• •22 verified contacts work at research companies in the 58.0 employee range (same size as Oculis).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Gudrun Bachmann directly?

Gudrun Bachmann's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Oculis. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Gudrun Bachmann work for?

Gudrun Bachmann is Chief Technology Officer at Oculis, a company in the research sector with 58.0 employees. The company is based in Geneva, Geneva.

Can I pitch or sell to Gudrun Bachmann?

As Chief Technology Officer at Oculis, Gudrun Bachmann is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Gudrun Bachmann directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Gudrun Bachmann in?

Gudrun Bachmann works in the research industry as Chief Technology Officer at Oculis. MessageCEO provides verified contact information for executives across all major industries.

Is Gudrun Bachmann's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Gudrun Bachmann's profile is kept up-to-date with the latest available information.

Last updated: July 21, 2026